2027 Co-op Cell Medicines Research & Development

Regeneron Pharmaceuticals, Inc.; Cambridge (MA); On-site; USD 30,000 - 39,000; Full time

Job summary

Regeneron is seeking an intern to support research activities within the Cell Medicines team, focusing on next-generation T-cell therapies for cancer. You will participate in in vitro safety and efficacy testing, develop tumor antigen expression assays, and assist with viral-vector production and process development.

The role involves GMP-compliant analytics, digital transformation support in biomanufacturing, and close collaboration with colleagues across the cell therapy team.

Qualifications

• Enrolled in an undergraduate or graduate program in Biology, Biochemistry, or Biomedical Engineering.
• Capable of committing 40 hours/week during specified terms.
• GPA of 3.0+ preferred.
• Demonstrated leadership qualities advantageous.

Responsibilities

• conduct in vitro safety and efficacy testing
• develop tumor antigen expression and flow cytometry assays
• contribute to viral-vector production and process development
• support high-throughput protein production and analytical method development compliant with GMP
• assist digital transformation initiatives in manufacturing
• document procedures and collaborate across the cell therapy team.

Skills

Leadership

40 hrs/week commitment

Education

Biology/Biochemistry/Biomedical Engineering (undergrad/grad)

Job description

Support research activities within Regeneron’s Cell Medicines (RCM) team focusing on next-generation T-cell therapies for cancer.

Responsibilities

• conduct in vitro safety and efficacy testing
• develop tumor antigen expression and flow cytometry assays
• contribute to viral-vector production and process development
• support high-throughput protein production and analytical method development compliant with GMP
• assist digital transformation initiatives in manufacturing
• document procedures and collaborate across the cell therapy team.

Qualifications

• enrolled in or accepted to an undergraduate or graduate program in Biology, Biochemistry, or Biomedical Engineering
• capable of committing 40 hours/week during specified terms
• GPA of 3.0+ preferred
• demonstrated leadership qualities advantageous.

HighValue

• cell therapy
• T-cell modalities
• cancer indications
• GMP manufacturing support
• in vitro and process development
• digital transformation in biomanufacturing

WorkSetup

• onsite in Cambridge, MA, or Seattle, WA, with full-time hours during specified periods
• no travel specified.